Heman Lapman Chao
Director/Board Member at Helix Immuno-Oncology SA
Heman Lapman Chao active positions
| Companies | Position | Start | End |
|---|---|---|---|
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Director/Board Member | - | - |
Career history of Heman Lapman Chao
Former positions of Heman Lapman Chao
| Companies | Position | Start | End |
|---|---|---|---|
| HELIX BIOPHARMA CORP. | Director/Board Member | 2017-12-11 | 2021-08-31 |
| Chief Executive Officer | 2017-03-30 | 2021-08-31 | |
| Chief Tech/Sci/R&D Officer | 2002-05-31 | 2021-08-31 | |
Sensium Technologies, Inc.
 Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | President | 2004-10-31 | 2008-03-31 |
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Corporate Officer/Principal | 1998-12-31 | 2002-05-31 |
Training of Heman Lapman Chao
| Queen's University | Doctorate Degree |
Statistics
International
| Canada | 4 |
| Poland | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HELIX BIOPHARMA CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Commercial Services |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
- Stock Market
- Insiders
- Heman Lapman Chao
- Experience
